MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciz287

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020

Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.

Tashiro Masato, Takazono Takahiro, Saijo Tomomi, Yamamoto Kazuko, Imamura Yoshifumi, Miyazaki Taiga, Kakeya Hiroshi, Ando Tsunehiro, Ogawa Kenji, Kishi Kazuma, Tokimatsu Issei, Hayashi Yuta, Fujiuchi Satoru, Yanagihara Katsunori, Miyazaki Yoshitsugu, Ichihara Kiyoshi, Mukae Hiroshi, Kohno Shigeru, Izumikawa Koichi

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

There are limited data for direct comparisons of the efficacy of oral itraconazole (ITCZ) and oral voriconazole (VRCZ) therapy in the treatment of chronic pulmonary aspergillosis (CPA).

METHODS

We conducted a retrospective, follow-up, observational study of CPA patients enrolled in 2 previous multicenter trials.

RESULTS

Of the 273 CPA patients, 59 and 101 patients started maintenance therapy with oral ITCZ and oral VRCZ, respectively, just after the end of acute intravenous therapy in each trial. At the end of the observation period in this follow-up study (median observation period, 731 days), the percentage of patients who showed improvement was lower in the ITCZ group than in the VRCZ group (18.2% vs 40.0%). However, after including stable patients, the percentages were 50.9% and 52.6%, respectively, in the ITCZ and VRCZ groups, which were not significantly different (P = .652). Multivariable Cox regression analysis showed no significant influence of the choice of initial maintenance treatment (ITCZ or VRCZ) on overall mortality as well as CPA-associated mortality. Multivariable logistic regression showed that oral ITCZ selection for initial maintenance therapy was an independent risk factor for hospital readmission and switching to other antifungal agents (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.3-7.5 and OR, 5.7; 95% CI, 2.0-15.7, respectively).

CONCLUSIONS

Oral VRCZ for initial maintenance therapy showed better effectiveness than oral ITCZ for clinical improvement in CPA patients. There was no difference in crude mortality between initial maintenance therapy with VRCZ and ITCZ, especially in elderly CPA patients.

CLINICAL TRIALS REGISTRATION: UMIN000007055.

Для цитирования: Tashiro Masato, Takazono Takahiro, Saijo Tomomi, Yamamoto Kazuko, Imamura Yoshifumi, Miyazaki Taiga, Kakeya Hiroshi, Ando Tsunehiro, Ogawa Kenji, Kishi Kazuma, Tokimatsu Issei, Hayashi Yuta, Fujiuchi Satoru, Yanagihara Katsunori, Miyazaki Yoshitsugu, Ichihara Kiyoshi, Mukae Hiroshi, Kohno Shigeru, Izumikawa Koichi. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. DOI: 10.1093/cid/ciz287.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.